Correlation Between Neuropace and DarioHealth Corp

Can any of the company-specific risk be diversified away by investing in both Neuropace and DarioHealth Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neuropace and DarioHealth Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Neuropace and DarioHealth Corp, you can compare the effects of market volatilities on Neuropace and DarioHealth Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neuropace with a short position of DarioHealth Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neuropace and DarioHealth Corp.

Diversification Opportunities for Neuropace and DarioHealth Corp

-0.23

Correlation Coefficient

Neuropace  DarioHealth Corp

Very good diversification

The 3 months correlation between Neuropace and DarioHealth is -0.23. Overlapping area represents the amount of risk that can be diversified away by holding Neuropace and DarioHealth Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DarioHealth Corp and Neuropace is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neuropace are associated (or correlated) with DarioHealth Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DarioHealth Corp has no effect on the direction of Neuropace i.e., Neuropace and DarioHealth Corp go up and down completely randomly.

Pair Corralation between Neuropace and DarioHealth Corp

Given the investment horizon of 90 days Neuropace is expected to generate 0.72 times more return on investment than DarioHealth Corp. However, Neuropace is 1.39 times less risky than DarioHealth Corp. It trades about 0.07 of its potential returns per unit of risk. DarioHealth Corp is currently generating about -0.02 per unit of risk. If you would invest  340.00  in Neuropace on December 4, 2024 and sell it today you would earn a total of  852.00  from holding Neuropace or generate 250.59% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Neuropace  vs.  DarioHealth Corp

Neuropace

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Neuropace are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady fundamental indicators, Neuropace may actually be approaching a critical reversion point that can send shares even higher in April 2025.

DarioHealth Corp

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in DarioHealth Corp are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very weak forward indicators, DarioHealth Corp displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Neuropace and DarioHealth Corp

The main advantage of trading using opposite Neuropace and DarioHealth Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neuropace position performs unexpectedly, DarioHealth Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DarioHealth Corp will offset losses from the drop in DarioHealth Corp's long position.

The idea behind Neuropace and DarioHealth Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.